0

    506128

    PARNAXLAB

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    PARNAX LAB LTD. Share Price Today

    Investment Returns

    Over 1 Month 16.15% Over 3 Months 8.72% Over 6 Months 15.96% Over 1 Year 43.48%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    PARNAX LAB LTD. fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 168.10
    • P/E Ratio (TTM) 190.06
    • Beta 0.96
    • Book Value / share 20.38
    • Return on equity 5.00%
    • EPS (TTM) 0.80
    • Dividend yield [-]%
    • Net profit/quarter (Cr) -0.55
    info icon alternate text

    PARNAX LAB LTD. Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 0.25
    Operating Expense 3.28
    Net Profit -0.55
    Net Profit Margin (%) -220.00
    Earnings Per Share (EPS) -0.48
    EBITDA -1.25
    Effective Tax Rate (%) 57.03
    Particulars DEC 2025 (Values in Cr)
    Revenue 2.71
    Operating Expense 1.95
    Net Profit 0.71
    Net Profit Margin (%) 26.19
    Earnings Per Share (EPS) 0.62
    EBITDA 0.97
    Effective Tax Rate (%) 25.26
    Particulars SEP 2025 (Values in Cr)
    Revenue 1.70
    Operating Expense 1.24
    Net Profit 0.49
    Net Profit Margin (%) 28.82
    Earnings Per Share (EPS) 0.43
    EBITDA 0.70
    Effective Tax Rate (%) 25.75
    Particulars JUN 2025 (Values in Cr)
    Revenue 1.97
    Operating Expense 1.84
    Net Profit 0.23
    Net Profit Margin (%) 11.67
    Earnings Per Share (EPS) 0.20
    EBITDA 0.34
    Effective Tax Rate (%) 25.80
    Particulars MAR 2025 (Values in Cr)
    Revenue 0.84
    Operating Expense 1.14
    Net Profit -0.08
    Net Profit Margin (%) -9.52
    Earnings Per Share (EPS) -0.07
    EBITDA -0.08
    Effective Tax Rate (%) 27.27
    Particulars MAR 2026 (Values in Cr)
    Revenue 6.63
    Operating Expense 8.30
    Net Profit 0.89
    Net Profit Margin (%) 13.42
    Earnings Per Share (EPS) 0.77
    EBITDA 0.74
    Effective Tax Rate (%) -36.92
    Particulars MAR 2025 (Values in Cr)
    Revenue 7.02
    Operating Expense 5.86
    Net Profit 1.39
    Net Profit Margin (%) 19.80
    Earnings Per Share (EPS) 1.21
    EBITDA 1.94
    Effective Tax Rate (%) 24.73
    Particulars MAR 2024 (Values in Cr)
    Revenue 7.44
    Operating Expense 5.52
    Net Profit 1.82
    Net Profit Margin (%) 24.46
    Earnings Per Share (EPS) 1.59
    EBITDA 2.65
    Effective Tax Rate (%) 25.30
    Particulars MAR 2023 (Values in Cr)
    Revenue 7.47
    Operating Expense 6.22
    Net Profit 1.20
    Net Profit Margin (%) 16.06
    Earnings Per Share (EPS) 1.09
    EBITDA 1.95
    Effective Tax Rate (%) 25.76
    Particulars MAR 2022 (Values in Cr)
    Revenue 7.15
    Operating Expense 6.54
    Net Profit 0.54
    Net Profit Margin (%) 7.55
    Earnings Per Share (EPS) 0.64
    EBITDA 1.53
    Effective Tax Rate (%) 30.76
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 72.35
    ROE % 14.92
    ROCE % 13.77
    Total Debt to Total Equity 0.97
    EBITDA Margin 15.15
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 62.32
    ROE % 14.39
    ROCE % 12.87
    Total Debt to Total Equity 1.01
    EBITDA Margin 12.91
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 54.11
    ROE % 15.64
    ROCE % 14.66
    Total Debt to Total Equity 1.12
    EBITDA Margin 14.18
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 47.24
    ROE % 20.47
    ROCE % 16.71
    Total Debt to Total Equity 1.59
    EBITDA Margin 14.33
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 38.26
    ROE % -1.13
    ROCE % 5.67
    Total Debt to Total Equity 1.69
    EBITDA Margin 11.27
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 19.63
    ROE % 5.00
    ROCE % 6.72
    Total Debt to Total Equity 0.00
    EBITDA Margin 27.64
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 18.42
    ROE % 6.54
    ROCE % 9.09
    Total Debt to Total Equity 0.03
    EBITDA Margin 35.62
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 16.85
    ROE % 4.77
    ROCE % 6.18
    Total Debt to Total Equity 0.32
    EBITDA Margin 25.97
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 11.14
    ROE % 3.98
    ROCE % 6.24
    Total Debt to Total Equity 1.18
    EBITDA Margin 21.40
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 5.54
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 2.13
    EBITDA Margin -16.03
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 2.68
    Total Assets 189.81
    Total Liabilities 189.81
    Total Equity 83.24
    Share Outstanding 1
    Price to Book Ratio 5.45
    Return on Assets (%) 6.06
    Return on Capital (%) 8.01
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1.87
    Total Assets 190.26
    Total Liabilities 190.26
    Total Equity 71.69
    Share Outstanding 1
    Price to Book Ratio 7.03
    Return on Assets (%) 5.05
    Return on Capital (%) 6.73
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 2.78
    Total Assets 145.07
    Total Liabilities 145.07
    Total Equity 62.26
    Share Outstanding 1
    Price to Book Ratio 3.09
    Return on Assets (%) 5.94
    Return on Capital (%) 7.62
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 5.78
    Total Assets 153.46
    Total Liabilities 153.46
    Total Equity 48.27
    Share Outstanding 0
    Price to Book Ratio 11.82
    Return on Assets (%) 5.37
    Return on Capital (%) 7.25
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 1.26
    Total Assets 106.25
    Total Liabilities 106.25
    Total Equity 32.62
    Share Outstanding 0
    Price to Book Ratio 3.52
    Return on Assets (%) -0.34
    Return on Capital (%) -0.41
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 1.27
    Total Assets 24.71
    Total Liabilities 24.71
    Total Equity 22.54
    Share Outstanding 1
    Price to Book Ratio 5.45
    Return on Assets (%) 5.64
    Return on Capital (%) 6.19
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.45
    Total Assets 22.23
    Total Liabilities 22.23
    Total Equity 21.15
    Share Outstanding 1
    Price to Book Ratio 7.03
    Return on Assets (%) 8.20
    Return on Capital (%) 8.62
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 1.28
    Total Assets 21.36
    Total Liabilities 21.36
    Total Equity 19.35
    Share Outstanding 1
    Price to Book Ratio 3.09
    Return on Assets (%) 5.63
    Return on Capital (%) 5.9
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 4.34
    Total Assets 23.53
    Total Liabilities 23.53
    Total Equity 12.74
    Share Outstanding 0
    Price to Book Ratio 11.82
    Return on Assets (%) 2.30
    Return on Capital (%) 2.47
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.11
    Total Assets 17.64
    Total Liabilities 17.64
    Total Equity 4.71
    Share Outstanding 0
    Price to Book Ratio 3.52
    Return on Assets (%) -6.41
    Return on Capital (%) -7.02
    Particulars MAR 2025 (Values in Cr)
    Net Income 15.67
    Cash from Operations 35.04
    Cash from Investing -16.39
    Cash from Financing -15.81
    Net change in Cash 0.09
    Free Cash Flow 44.79
    Particulars MAR 2024 (Values in Cr)
    Net Income 12.04
    Cash from Operations 18.51
    Cash from Investing -31.51
    Cash from Financing 14.81
    Net change in Cash -0.82
    Free Cash Flow 32.65
    Particulars MAR 2023 (Values in Cr)
    Net Income 12.27
    Cash from Operations 23.77
    Cash from Investing -9.92
    Cash from Financing -14.06
    Net change in Cash -3.08
    Free Cash Flow 35.05
    Particulars MAR 2022 (Values in Cr)
    Net Income 12.26
    Cash from Operations 8.78
    Cash from Investing -16.49
    Cash from Financing 12.13
    Net change in Cash 4.18
    Free Cash Flow 26.61
    Particulars MAR 2021 (Values in Cr)
    Net Income -0.08
    Cash from Operations 7.06
    Cash from Investing -6.56
    Cash from Financing 0.05
    Net change in Cash -0.20
    Free Cash Flow 11.61
    Particulars MAR 2025 (Values in Cr)
    Net Income 1.85
    Cash from Operations 0.30
    Cash from Investing -0.19
    Cash from Financing -0.02
    Net change in Cash 0.06
    Free Cash Flow 0.30
    Particulars MAR 2024 (Values in Cr)
    Net Income 2.44
    Cash from Operations 0.09
    Cash from Investing 0.30
    Cash from Financing -1.21
    Net change in Cash -0.82
    Free Cash Flow 0.21
    Particulars MAR 2023 (Values in Cr)
    Net Income 1.62
    Cash from Operations -0.26
    Cash from Investing 0.13
    Cash from Financing -2.92
    Net change in Cash -3.06
    Free Cash Flow -0.21
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.77
    Cash from Operations -0.35
    Cash from Investing 0.00
    Cash from Financing 4.59
    Net change in Cash 4.23
    Free Cash Flow -0.35
    Particulars MAR 2021 (Values in Cr)
    Net Income -1.25
    Cash from Operations 0.47
    Cash from Investing 0.00
    Cash from Financing -0.47
    Net change in Cash 0.00
    Free Cash Flow 0.47
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.72 13.52 1.58 250.74 23.12 38.85
    BLISS GVS PHARMA LTD 506.15 40.69 4.49 5368.04 118.35 552.90
    CIPLA LTD. 1458.45 30.95 3.42 117820.20 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 345.85 15.26 2.50 1017.87 256.40 399.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.72 22.88 4.21 250.74 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 536.85 24.06 4.19 1552.07 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8297.90 108.37 23.76 20744.75 7630.00 9850.00
    BLISS GVS PHARMA LTD 506.15 54.72 4.64 5368.04 118.35 552.90

    PARNAX LAB LTD. shareholding pattern

    Holding
    27.7%
    72.29%
    9.41%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    PARNAX LAB LTD. Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    146.35 1.59 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 140.50
    • 26 Days 137.70
    • 10 Days 137.90
    • 50 Days 139.20
    • 12 Days 137.50
    • 100 Days 137.40
    • 20 Days 137.20
    • 200 Days 133.00
    143.02 PIVOT
    First Support 138.03 First Resistance 149.03 Second Support 132.02 Second Resistance 154.02 Third Support 127.03 Third Resistance 160.03
    RSI 58.77 ADX 19.55 MACD -0.28 Williams % R -30.89 Commodity Channel Index (CCI) 259.47
    Date 2026-07-03 Week 7921.00 Same Day 13818.00 Month 4794.00
    1 Year 0.97 3 Year 0.73
    Over 1 Month
    16.15% down
    Over 1 Year
    43.48% down
    Over 3 Months
    8.72% down
    Over 3 Years
    32.99% down
    Over 6 Months
    15.96% down
    Over 5 Years
    41.38% down

    PARNAX LAB LTD. Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Parnax Lab Ltd?

    Answer Field

    Parnax Lab Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 146.35 as on Jul 06 2026 11:13 AM.

    What is the Market Cap of Parnax Lab Ltd Share?

    Answer Field

    The market cap of Parnax Lab Ltd for NSE ₹ 0.00 & for BSE ₹ 168.10 as on Jul 06 2026 11:13 AM.

    What is the 52 Week High and Low of Parnax Lab Ltd?

    Answer Field

    The 52 Week High and Low of Parnax Lab Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 182.00 and ₹ 96.25.

    What is 1 year return for Parnax Lab Ltd?

    Answer Field

    The 1 year returns on the stock has been 43.48%.

    What is the P/E Ratio of Parnax Lab Ltd Share?

    Answer Field

    As on Jul 06 2026 11:13 AM the price-to-earnings (PE) ratio for Parnax Lab Ltd share is 190.06.

    What is the PB ratio of Parnax Lab Ltd Share?

    Answer Field

    As on Jul 06 2026 11:13 AM, the price-to-book (PB) ratio for Parnax Lab Ltd share is 20.38.

    How to Buy Parnax Lab Ltd Share?

    Answer Field

    You can trade in Parnax Lab Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Parnax Lab Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Parnax Lab Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Parnax Lab Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |